Flexible solutions. Your success.

China is moving forward to become more attractive for clinical research and market labelling approvals

China is moving forward to become more attractive for clinical research and market labelling approvals

Chinese Food and Drug Administration (CFDA) is under reorganization and investing on additional resources for a smoother process for overseeing drugs, foods, medical devices, testing and evaluation.

Chinese Health Policy and Regulatory Authorities Overview 2019 04

Trusting staff to work flexibly is key in the talent stakes

With more than 90% of Millennials saying flexible working is important to them, firms that don’t trust their staff to do so responsibly risk alienating and deterring talent.

 

 

 

 

 

 

 

https://www.regus.co.uk/work-uk/trusting-staff-work-flexibly-key-talent-stakes/?utm_campaign=Newsletter.Regus.June_2&utm_medium=email&utm_source=Eloqua&elqTrackId=a9f5c15afb8144a88c359923ccd108f3&elq=d011625c3d0a4d5d946171c73c549239&elqaid=3298&elqat=1&elqCampaignId=2220&elqcst=272&elqcsid=8053176

A Roadmap for Implementing Risk-Based Monitoring and Quality Management

 

Are you implementing or preparing to implement RBM and risk-based quality management approaches? Johann Prove presented at 2018 DIA a roadmap beginning with a look at pre-study risk planning, vendor selection and change management in RBM and RBQM.

Read full article at:

http://www.appliedclinicaltrialsonline.com/roadmap-implementing-risk-based-monitoring-and-quality-management